Why the study?
Does pretreatment with PGI2 and theophylline affect shear-induced platelet aggregation and lysis in human platelets?
Does pretreatment with PGI2 and theophylline affect shear-induced platelet aggregation and lysis in human platelets?
While PGI2 and theophylline reduce shear-induced platelet aggregation, they paradoxically increase platelet fragility and lysis at higher shear stress levels, which may have clinical implications for PGI2 use.
Answers are grounded in this paper and cite their sources.
May increase lysis risk at high shear despite lower aggregation; leaves open translation to human platelets.
A specially designed rotational viscometer was used to investigate the effects of the antiplatelet agent PGI2 in combination with theophylline on the response of human platelets subjected to shear stress. Samples of citrated platelet-rich plasma (PRP) were exposed to shear stress in the viscometer for a period of 5 min at 23 degrees C. The levels of stress studied ranged from 50 to 300 dynes/sq cm. Pretreatment of the platelets with 0.01 microM PGI2 and 500 microM theophylline before exposure to shear stress caused a large reduction in shear-induced platelet aggregation. However, it was also observed that the PGI2--theophylline pretreatment concomitantly caused a large increase in shear-induced platelet lysis and serotonin release at stress levels equal to or greater than 150 dynes/sq cm. This observed increase in platelet fragility may have important implications for clinical applications of PGI2. The results are discussed and compared to those obtained in prior work in which platelets were pretreated with acetylsalicylic acid or with PGE1.
No takes yet. Share an insight, caveat, or question.
Hardwick et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: